Glenview State Bank Trust DEPT. Acquires 342 Shares of Monsanto Co. (MON)
Glenview State Bank Trust DEPT. raised its stake in shares of Monsanto Co. (NYSE:MON) by 2.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,843 shares of the company’s stock after buying an additional 342 shares during the period. Glenview State Bank Trust DEPT.’s holdings in Monsanto were worth $1,535,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of MON. State Street Corp raised its position in Monsanto by 0.9% in the first quarter. State Street Corp now owns 18,623,044 shares of the company’s stock valued at $1,634,002,000 after buying an additional 173,201 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Monsanto by 5.2% in the first quarter. Geode Capital Management LLC now owns 3,718,453 shares of the company’s stock valued at $325,622,000 after buying an additional 182,728 shares during the period. Legal & General Group Plc boosted its stake in shares of Monsanto by 2.5% in the first quarter. Legal & General Group Plc now owns 1,944,838 shares of the company’s stock valued at $170,663,000 after buying an additional 46,878 shares during the period. Carmignac Gestion purchased a new stake in shares of Monsanto during the second quarter valued at $197,555,000. Finally, UBS Asset Management Americas Inc. boosted its stake in shares of Monsanto by 0.5% in the first quarter. UBS Asset Management Americas Inc. now owns 1,731,414 shares of the company’s stock valued at $151,914,000 after buying an additional 8,453 shares during the period. 78.94% of the stock is owned by institutional investors and hedge funds.
Monsanto Co. (NYSE:MON) traded up 0.56% during midday trading on Tuesday, hitting $102.74. 1,600,178 shares of the company traded hands. The stock has a 50 day moving average of $104.25 and a 200 day moving average of $102.04. Monsanto Co. has a 12-month low of $83.73 and a 12-month high of $114.26. The stock has a market cap of $44.97 billion, a P/E ratio of 34.38 and a beta of 1.19.
Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. The business had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business’s revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.19) EPS. Equities research analysts predict that Monsanto Co. will post $4.89 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be given a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 2.11%. The ex-dividend date is Wednesday, October 5th. Monsanto’s dividend payout ratio is currently 71.05%.
Several analysts recently weighed in on MON shares. S&P Equity Research reaffirmed a “positive” rating on shares of Monsanto in a report on Thursday, September 15th. Vetr raised shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $116.55 target price on the stock in a report on Monday, June 27th. Piper Jaffray Cos. reaffirmed an “overweight” rating and issued a $118.00 target price on shares of Monsanto in a report on Sunday, August 21st. Citigroup Inc. reaffirmed a “neutral” rating and issued a $112.00 target price on shares of Monsanto in a report on Monday, July 18th. Finally, Goldman Sachs Group Inc. set a $92.00 target price on shares of Monsanto and gave the company a “sell” rating in a report on Monday, June 27th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $114.65.
In other Monsanto news, EVP Steven Mizell sold 310 shares of the stock in a transaction on Monday, October 10th. The stock was sold at an average price of $103.09, for a total value of $31,957.90. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Charles S. Mcmillan bought 3,500 shares of the company’s stock in a transaction on Monday, October 10th. The stock was bought at an average cost of $103.23 per share, for a total transaction of $361,305.00. Following the completion of the transaction, the director now directly owns 64,009 shares of the company’s stock, valued at $6,607,649.07. The disclosure for this purchase can be found here. Corporate insiders own 0.88% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.